[1]
T. A. Wihastuti, D. Z. P. Andiyani, S. Andarini, and T. Heriansyah, “DECREASEMENT OF LYSOPHOSPHATIDYLCHOLINE LEVEL, NF-KB EXPRESSION, INTIMA MEDIA THICKNESS AND IMPROVEMENT OF INSULIN RESISTANCE BY DARAPLADIB TREATMENT: IN VIVO STUDIES OF TYPE 2 DIABETES MELLITUS SPRAGUE-DAWLEY RAT MODEL”, Asian J Pharm Clin Res, vol. 10, no. 12, pp. 362–365, Dec. 2017.